IP Library Patent Application 17302073
Patent Application
App. No. 17/302,073

NEUROMODULATION SYSTEM FOR PLANNING AND/OR ADJUSTING AND/OR PROVIDING A NEUROMODULATION THERAPY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/302,073
Abstract

A neuromodulation system for planning, adjusting, and providing a neuromodulation therapy, comprising: at least one neuromodulation means configured to provide neuromodulation at least partially by means of neurostimulation; at least one neuromodulation controller configured to control the neuromodulation means, wherein the neuromodulation controller is further configured to control the neuromodulation means at the beginning of a neuromodulation action including neurostimulation that the neurostimulation comprises a starting sequence and/or at the end of a neuromodulation action including neurostimulation that the neurostimulation comprises an ending sequence.

Claims (16)

1 . A neuromodulation system for planning and/or adjusting and/or providing a neuromodulation therapy, comprising:

at least one neuromodulation means configured to provide neuromodulation at least partially by means of neurostimulation;

at least one neuromodulation controller configured to control the neuromodulation means,

wherein the neuromodulation controller is further configured to control the neuromodulation means at the beginning of a neuromodulation action including neurostimulation that the neurostimulation comprises a starting sequence and/or at the end of a neuromodulation action including neurostimulation that the neurostimulation comprises an ending sequence.

2 . The neuromodulation system according to claim 1 , wherein the neurostimulation comprises stimulation parameters, wherein the stimulation parameters comprise power, amplitude, current, voltage, pulse width, frequency and/or duration.

3 . The neuromodulation system according to claim 2 , wherein at least one stimulation parameter of the starting sequence and/or ending sequence has a lower level compared to the at least one stimulation parameter of the normal stimulation.

4 . The neuromodulation system according to claim 1 , wherein at least one stimulation parameter is increased during the starting sequence and/or decreased during the ending sequence.

5 . The neuromodulation system according to claim 4 , wherein the increase the at least one stimulation parameter is a linear, non-linear, exponential, polynomic and/or stepwise increase and that the decrease of the at least one stimulation parameter is a linear, non-linear, exponential, polynomic and/or stepwise decrease.

6 . The neuromodulation system according to claim 1 , wherein the starting sequence includes a pre-pulse (PP), wherein at least one stimulation parameter of the pre-pulse (PP) is of a lower level compared to the at least one stimulation parameter of a normal stimulation pulse.

7 . The neuromodulation system according to claim 1 , wherein the starting sequence and/or the ending sequence includes a pulse ramping.

8 . The neuromodulation system according to claim 7 , wherein the pulse ramping includes a ramping up from a starting level of at least one stimulation parameter to a higher level of the at least one stimulation parameter used for the neurostimulation and/or a ramping down from a level of at least one stimulation parameter used for the neurostimulation to a lower level of the at least one stimulation parameter, below the threshold used for neurostimulation.

9 . The neuromodulation system according to claim 1 , wherein the level of at least one stimulation parameter of the starting sequence and ending sequence is determined manually and/or automatically based on response data.

10 . The neuromodulation system according to claim 1 , wherein the neuromodulation is planned to be provided and/or provided to a spatial area of a patient, wherein the spatial area during the starting sequence and/or ending sequence is limited compared to the spatial area during the stimulation after the starting sequence and/or before the ending sequence.

11 . The neuromodulation system according to claim 1 , wherein the starting sequence and/or ending sequence comprises a pre-warning signal and stop-warning signal.

12 . The neuromodulation system according to claim 11 , wherein the pre-warning signal and/or stop-warning signal is an acoustic, visual, haptic, electrical, sensory and/or temperature signal.

13 . The use of a system for planning, adjusting, and providing a neuromodulation therapy according to claim 1 in a method for the treatment of a patient suffering from at least one of a spinal cord injury, stroke, traumatic injury, Parkinson disease, cerebral palsy, multiple sclerosis, autonomic failure, autonomic neuropathy, and cancer of the neurological tissue.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE TYPOGRAPHICAL ERROR THAT LISTED APPLICTION NO. 29/782, 452 INSTEAD OF APPLICATION NO. 29782,453 PREVIOUSLY RECORDED AT REEL: 058600 FRAME: 0518. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 1, 2022
From: ONWARD MEDICAL B.V.
To: ONWARD MEDICAL N.V.
Reel/Frame 059280/0326 →
CHANGE OF NAME Recorded Dec 28, 2021
From: ONWARD MEDICAL B.V.
To: ONWARD MEDICAL N.V.
Reel/Frame 058600/0518 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2021
From: CABAN, MIROSLAV; VON ZITZEWITZ, JOACHIM; DELATTRE, VINCENT; COURTINE, GRÉGOIRE; KOMI, SALIF; DEMESMAEKER, ROBIN; WAGNER, FABIEN
To: ONWARD MEDICAL B.V.
Reel/Frame 056631/0135 →